Metabolic Stack · Ipamorelin Retatrutide + Ipamorelin + MOTS-c · Research Peptide Stack — Canada
The Metabolic Stack · Ipamorelin combines Retatrutide, Ipamorelin and MOTS-c for metabolic research. The Metabolic Stack with Ipamorelin in place of Tesamorelin.
The same idea as the Metabolic Stack, with ipamorelin in place of tesamorelin: the growth-hormone angle comes through the ghrelin receptor instead of GHRH, alongside retatrutide's hormone signalling and MOTS-c's cell-energy research.
$222.00 CAD ($15.00 less than buying separately, $237.00) — In stock. Flat $20.00 shipping, free over $300.00.
- Retatrutide 10mg — $89.00
- Ipamorelin 10mg — $59.00
- MOTS-c 40mg — $89.00
Reviewed 2026-11-08 by the Peak Peptides research team. 6 studies cited.
How they fit together
Hormone signals
Gut hormones that regulate appetite and blood sugar.
- Retatrutide: Activates the GLP-1, GIP and glucagon receptors at once.
Growth-hormone signal
The ghrelin-receptor route to growth-hormone release.
- Ipamorelin: Activates the ghrelin receptor; described in 1998 as the first selective GH secretagogue.
Cell energy
How cells sense fuel and burn it.
- MOTS-c: AMPK energy sensing and PGC-1α in mouse models.
Insulin sensitivity
How well cells respond to insulin.
- Retatrutide: Glucose control in type 2 diabetes trials.
- MOTS-c: Insulin sensitivity and glucose handling in mouse models.
How they compare
| Compound | What it is | Pathway studied | Studied in | Evidence | Key study |
|---|---|---|---|---|---|
| Retatrutide | Triple-agonist peptide | GLP-1, GIP and glucagon receptors | Body weight, Glucose control, Liver fat | Phase 2 and 3 human trials | Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity. (2026), PMID 42814954 |
| Ipamorelin | Selective growth-hormone secretagogue | Ghrelin receptor and growth hormone | Selective GH release, Bone growth, Gut motility | Animal and early human studies | Ipamorelin, the first selective growth hormone secretagogue. (1998), PMID 9849822 |
| MOTS-c | 16-amino-acid mitochondrial peptide | AMPK energy sensing and PGC-1α | Insulin sensitivity, AMPK signalling, Exercise & ageing | Animal studies | The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. (2015), PMID 25738459 |
Key studies
- Retatrutide: Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity. (phase 3 trial, 2026). 80-week randomised trial in 2,339 adults with obesity.
- Retatrutide: Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial. (phase 2 trial, 2023). 48-week randomised trial in 338 adults.
- Ipamorelin: Ipamorelin, the first selective growth hormone secretagogue. (preclinical, 1998). Growth-hormone release without notable ACTH or cortisol change.
- Ipamorelin: Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers. (clinical, 1999). Growth-hormone response modelled in healthy volunteers.
- MOTS-c: The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. (discovery, 2015). First description of MOTS-c and its metabolic actions in mice.
- MOTS-c: MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. (preclinical, 2021). Physical capacity in young, middle-aged and old mice.
Related stacks
- GH Stack: Ipamorelin + Tesamorelin, $138.00 CAD
- Metabolic Stack: Retatrutide + Tesamorelin + MOTS-c, $252.00 CAD
- Recomp Stack: Retatrutide + Tesamorelin + Ipamorelin, $222.00 CAD
- Longevity Stack: NAD+ + MOTS-c + Epithalon, $252.00 CAD
Related research
- Retatrutide Canada Approval: TRIUMPH Phase 3 Results 2026
- Tesamorelin vs Ipamorelin vs Sermorelin: Receptors, Evidence and Regulatory Status Compared
- Do Peptides Cause Cancer? What the Research Actually Shows (2026)
Metabolic Stack · Ipamorelin, answered
What is the Metabolic Stack · Ipamorelin?
The Metabolic Stack · Ipamorelin combines Retatrutide, Ipamorelin and MOTS-c for metabolic research. The Metabolic Stack with Ipamorelin in place of Tesamorelin.
Why are Retatrutide, Ipamorelin and MOTS-c researched together?
The Metabolic Stack with ipamorelin, a selective growth-hormone secretagogue, in place of tesamorelin, for models that focus on the ghrelin-receptor pathway alongside retatrutide and MOTS-c.
How much does the Metabolic Stack · Ipamorelin cost?
The Metabolic Stack · Ipamorelin is $222.00 CAD, $15.00 less than buying Retatrutide, Ipamorelin and MOTS-c separately ($237.00). Shipping is a flat $20.00 across Canada, free on orders over $300.00.
Where can I buy the Metabolic Stack · Ipamorelin in Canada?
Peak Peptides ships the Metabolic Stack · Ipamorelin from Toronto to every province and territory, tracked and in discreet packaging. Orders paid before 12 PM (Toronto time) are dispatched the same day; delivery takes 1–3 business days in Ontario and 3–5 elsewhere in Canada.
What's the difference between the two Metabolic stacks?
They share retatrutide and MOTS-c. This one uses ipamorelin, which works through the ghrelin receptor; the original uses tesamorelin, a GHRH analogue studied for visceral fat.
How is each compound tested?
Third-party tested, >98% purity, COA published. Each product page links the certificate of analysis for the current batch.
How is the Metabolic Stack · Ipamorelin supplied?
Each compound comes as a lyophilised powder in its own sealed vial, for laboratory research use only. Store at −20°C, dry and dark, and keep sealed and lyophilised until use.